Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
Teva x Sankuanz Team Up for Hurricane Sandal at Opening Ceremony – Footwear News
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva's flagship drug Austedo scores new approval at the FDA
Teva CEO Schultz likely won't renew employment contract: reports
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
New York could get $524M under opioid settlements with Teva - ABC News
Analysts have given Teva Pharmaceutical Industries Limited (NYSE:TEVA) an average recommendation of "Hold." - Best Stocks
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
